Jain Irrigation Systems Limited has informed the Exchange about Transcript
JISLDVREQS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jain Irrigation Systems reported Q4 FY25 consolidated revenue of ~INR1,750 crores (up 1.3% YoY) and EBITDA of ~INR225 crores (up 3%), with PAT of INR28 crores versus a loss in the year-ago quarter. The Hi-Tech division (micro irrigation and tissue culture) grew 16.8% and Agro Processing grew 14.6%, while the plastic piping business declined due to weak Jal Jeevan Mission orders and lower PVC resin prices. For full-year FY25, revenue was ~INR5,800 crores (down 6%) and EBITDA ~INR717 crores (down 9%), but the company generated strong operating cash flow of ~INR842 crores and reduced debt by INR257 crores to ~INR3,500 crores. Management guided for FY26 revenue growth in the high teens (~18%+), EBITDA growth of 23-24% (better than revenue on operating leverage), and debt reduction of at least INR400 crores (INR4,000+ crores), with plans to prepay NCDs ahead of their FY27-28 maturity. Key growth drivers cited are tissue culture (20-30% growth), solar pumps (Kusum scheme), exports (25-30%), and recovery in MIS business as some states clear payments.
Positive for shareholders — management has laid out a clear deleveraging path (debt from ~INR7,000 crores two years ago to ~INR3,000 crores by FY26 end, targeting ~2x EBITDA by FY27-28) alongside high-teens revenue and stronger EBITDA growth, which should support earnings improvement and reduce interest costs (~INR20 crores savings next year). Possible upside from government receivable inflows (INR400-450 crores expected in FY26) and any listing of the Jain Farm Fresh subsidiary.